Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention COSMOS Trial, the most common co-covered peer. Each carries 57 original sources on average. We currently track 1 Biotech story that mention Brigham and Women's Hospital, all published on March 9, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Brigham and Women's Hospital
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention COSMOS Trial, the most common co-covered peer. Each carries 57 original sources on average. We currently track 1 Biotech story that mention Brigham and Women's Hospital, all published on March 9, 2026.
Stories tracked
1
Sources per story
57
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Brigham and Women's Hospital. Shared-story counts are live from our verified record — not editorial picks.
A significant new clinical study indicates that daily multivitamin supplementation may slow biological aging in older adults by approximately two years. The findings suggest that consistent micronutrient intake supports cellular health and mitigates the epigenetic markers associated with age-related decline.
Brigham and Women's Hospital is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.